Skip to main content

Table 2 Clinical and background variables of each eGFR category

From: Prevalence and risk factors of chronic kidney disease among Palestinian type 2 diabetic patients: a cross-sectional study

eGFR Stage

(n)

5: GFR ≥ 90

(n = 127)

4: GFR = 60–89

(n = 168)

3: GFR = 30–59

(n = 76)

2: GFR = 15–29(n = 10)

1: GFR < 15

(n = 5)

P value*

Age (years)

53.1 ± 9.4

63.2 ± 8.9

67.2 ± 7.3

62.1 ± 9.8

65 ± 12.5

< 0.001

Systolic BP (mmHg)

133 ± 16.5

139.3 ± 17.7

139.2 ± 19.9

153 ± 15.6

154 ± 22

< 0.001

Diastolic BP (mmHg)

77.7 ± 11.4

76.5 ± 11.2

77.5 ± 10.5

80.1 ± 14

81.4 ± 6.8

0.883

Hypertension Duration (years)

6.5 ± 5

9.0 ± 7.4

11.0 ± 9

11.6 ± 13.3

12.6 ± 6.8

0.013

HbA1c (%)

8.58 ± 2

8.38 ± 1.98

8.57 ± 2.2

7.3 ± 1.7

6.4 ± 1.14

0.057

Diabetes Duration (years)

9.3 ± 6.6

12.9 ± 8.4

14.9 ± 8.8

16.8 ± 13.2

21.4 ± 9.8

0.007

  1. *Kruskal Wallis test, BP Blood Pressure, eGFR Estimated glomerular filtration rate